Healthcare Services (HS1) Q3 2026 Earnings Report
DE:HS1 Q3 2026 EPS Results
- Actual EPS
- EUR 0.32
- Consensus EPS
- EUR 0.21
- Beat/Miss
- Beat by +EUR 0.11
- One Year Ago EPS
- EUR 0.21
DE:HS1 Q3 2026 Revenue Results
- Actual Revenue
- EUR 428.00M
- Expected Revenue
- EUR 429.07M
- Beat/Miss
- Missed by -EUR 1.06M
- YoY Revenue Growth
- +3.29%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/21/2026
- Time
- Before Open
- Conference Call
- Wednesday, October 21, 2026
Healthcare Services's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was strongly positive, with robust third-quarter execution, revenue of $479.6 million, improving bad debt performance, a substantial liquidity position, the NEXDINE acquisition, and a raised 2027 growth outlook. Management also highlighted demographic tailwinds, strong client retention, and continued organic momentum. The principal challenges were uncertainty around additional Genesis recoveries, the volatility of bad debt and workers' compensation, M&A-related SG&A and lost interest income, and timing-related cash flow fluctuations.
Guidance calls for Q4 revenue in the range of $535 million-$545 million, with NEXDINE expected to contribute over $150 million in annual revenue at comparable margins and be immediately accretive to earnings; 2027 revenue growth is being raised from the mid-single digits to low double digits, inclusive of a mid-single-digit growth target organically, while NEXDINE is viewed as a double-digit growth opportunity. Cost of services is expected to be managed in the 86% range, SG&A in the 9.5%-10.5% range with the longer-term goal of 8.5%-9.5%, and the 2026 effective tax rate is expected to be approximately 25%. For cash flow, Q4 is expected to have an $18 million negative impact from a six-day decrease in accrual days from 11 days in Q3 to five days in Q4; 2027 Q1 is expected to have a $19 million positive effect from a six-day increase to 11 days, Q2 about a -$9 million effect from a two-day decrease to nine days, Q3 about a $13 million positive effect from a two-day increase to 11 days, and Q4 of 2027 an $18 million or so negative effect from a five-day decrease to six days.
- Ninth Consecutive Sequential Revenue IncreaseThird-quarter revenue was $479.6 million, representing the ninth sequential revenue increase over the past 10 quarters. Management attributed the top-line growth to new client wins and high retention rates.
- Environmental and Dietary Services PerformanceEnvironmental Services reported revenue of $217.2 million with a 13.3% segment margin, while Dietary Services reported revenue of $262.4 million with an 8.7% segment margin.
- Strong Cost of Services PerformanceCost of services was $399.2 million, or 83.2%, below the company's goal of managing cost of services in the 86% range. Management cited strong service execution, customer experience, systems adherence, regulatory compliance, and budget discipline as drivers.
- Lower Bad Debt ExpenseExcluding the Genesis assessment, quarterly bad debt expense was approximately $2.5 million, or less than half a percent of revenue. Management said this would have been the company's lowest bad debt amount in the last six quarters, compared with a historical pre-CECL average of 1%-1.5% of revenue.
- NEXDINE Acquisition Expands PlatformThe October 6 acquisition of NEXDINE Hospitality expands HCSG's footprint in senior living and hospitality-driven markets and deepens its service capabilities. NEXDINE is expected to contribute over $150 million in annual revenue at comparable margins and be immediately accretive to earnings.
- NEXDINE Growth and Contract ProfileManagement currently views NEXDINE as a double-digit growth opportunity. NEXDINE has contracts that allow it to pass along price increases, and management said its margin profile is similar to HCSG's overall company profile.
- Positive Organic Growth MomentumManagement said the organic growth inflection it planned for is now being delivered, supported by a strong new-business pipeline, management-candidate development, and retention of greater than 90% of the base business.
- Raised 2027 Revenue Growth OutlookFourth-quarter revenue is expected to be in the range of $535 million-$545 million. Management raised its 2027 revenue growth outlook from the mid-single digits to low double digits, inclusive of mid-single-digit organic growth and NEXDINE Hospitality.
- Genesis Restructuring MilestoneThe Bankruptcy Court approved the sale of Genesis to 101 West State Street on October 14. Management said the restructuring creates stronger, healthier HCSG client facilities, provides balance sheet clarity, and enables future expansion opportunities with a growth-oriented client partner.
- Genesis Recovery BenefitHCSG's current estimated recovery of pre-petition claims is $6.1 million. The amount flows through the P&L as a bad debt offset, benefits cost of sales, and flows through to net income on a post-tax basis.
- Demographic Industry TailwindsManagement highlighted a multi-decade demographic tailwind, noting that the first baby boomers are turning 80 in 2026 and that by 2030 all 70 million+ boomers will be over age 65. Management expects demand and opportunities for senior care service providers to increase in the months and years ahead.
- Margin Protection Through Contractual FrameworksDespite sustained volatility in energy and supply markets, management said longstanding vendor partnerships provide visibility to pivot sourcing and mitigate direct exposure. Enhanced contractual frameworks allow HCSG to pass through unavoidable cost increases while preserving margins.
- SG&A Within Short-Term Target RangeSG&A was $48.5 million, or $49.1 million after adjusting for a $600,000 decrease in deferred compensation, representing 10.2% of revenue. This was within the company's 9.5%-10.5% short-term management range.
- Quarterly Earnings and Tax MetricsNet income was $24.9 million and diluted earnings per share were $0.36. The effective tax rate was 26.2%, and management expects the 2026 effective tax rate to be approximately 25%.
- Strong Liquidity PositionCash flow from operations was $30.2 million, or $20.7 million after adjusting for a $9.5 million decrease in the payroll accrual. At quarter-end, HCSG had $204.3 million of cash and marketable securities and an unutilized $300 million credit facility.
- Share Repurchase ProgressHCSG repurchased $11.7 million of common stock in the third quarter, bringing year-to-date repurchases to $56.6 million. The company has 7.7 million shares remaining under its share repurchase authorization and previously targeted $75 million of repurchases over 12 months.
- Continued Investment and M&A FlexibilityManagement said it continues to execute capital allocation priorities across organic growth, M&A, and share repurchases. The balance sheet is described as providing flexibility to pursue all three priorities in tandem, while the company continues investing in people, training, technology, and potential acquisitions.
- NEXDINE Integration ProgressHCSG has a comprehensive NEXDINE integration plan covering corporate functions and individual departments. Accounting, finance, and reporting integration is well underway, and management expects internal integration milestones to be completed by year-end.
DE:HS1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 0.24- | 0.39 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 0.210.32 | 0.21 | 56.52% (+0.12) | |
| Jul 22, 2026 | 2026 (Q2) | 0.200.29 | 0.19 | 52.38% (+0.10) | |
| Apr 22, 2026 | 2026 (Q1) | 0.190.33 | 0.21 | 60.87% (+0.12) | |
| Feb 11, 2026 | 2025 (Q4) | 0.200.39 | 0.14 | 175.00% (+0.25) | |
| Oct 22, 2025 | 2025 (Q3) | 0.180.21 | 0.17 | 21.05% (+0.04) | |
| Jul 23, 2025 | 2025 (Q2) | 0.180.19 | -0.02 | 1150.00% (+0.21) | |
| Apr 23, 2025 | 2025 (Q1) | 0.170.21 | 0.2 | 4.55% (+0.01) | |
| Feb 12, 2025 | 2024 (Q4) | 0.180.14 | 0.18 | -20.00% (-0.04) | |
| Oct 23, 2024 | 2024 (Q3) | 0.180.17 | 0.15 | 11.76% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
